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ABSTRACT (262 words)  
 
Objectives: To describe the frequency and nature of premedications used prior to neonatal 
endotracheal intubation. To confront observed practice with current recommendations. To 
identify risk factors for the absence of premedication. 
Design, Setting and Patients: Data concerning intubations were collected prospectively at 
the bedside as part of an observational study collecting around-the-clock data on all painful or 
stressful procedures performed in neonates during the first 14 days of their admission to 13 
tertiary care units in the region of Paris, France between 2005 and 2006. 
Interventions: Observational study. 
Measurements and Main Results: Specific premedication prior to endotracheal intubation 
was assessed. Ninety one intubations carried out on the same number of patients were 
analysed. The specific premedication rate was 56% and included mostly opioids (67%) and 
midazolam (53%). When compared to recent guidance from the American Academy of 
Pediatrics, used premedications could be classified as "preferred" (12%), "acceptable" (18%),  
"not recommended" (27%) or "not described" (43%). In univariate analysis, infants without a 
specific premedication when compared to others were younger at the time of intubation 
(median age: 0.7 vs 2.0 days), displayed significantly more frequent spontaneous breathing at 
the time of intubation (31% vs 12%) and a higher percentage of analgesia for all other painful 
procedures (median values : 16% vs 6%). In multivariate analysis, no factor remained 
statistically significant. 
Conclusions: Premedication use prior to neonatal intubation was not systematically used and 
when used it was most frequently inconsistent with recent recommendations. No patient- or 
centre-related independent risk factor for the absence of premedication was identified in this 
study. 
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INTRODUCTION : 
Endotracheal intubation is a frequent procedure in neonates. Premedication including an 
analgesic and/or a sedative agent is considered crucial to decrease pain and discomfort(1), to 
facilitate intubation(2, 3) and to decrease adverse reactions such as bradycardia(2) or 
increased intracranial pressure(4).  In older children(5) and adults(6), emergency tracheal 
intubation is usually performed after adequate anesthesia which frequently includes the 
combination of a central analgesic, a sedative and a neuromuscular blocker. In neonates, no 
consensus guidelines exist regarding the optimal drug or drug combination. Recent guidance 
for the clinician from the American Academy of Pediatrics (AAP) recommends the systematic 
use of rapid onset premedication except for emergent intubation during resuscitation(7).  
In spite of the need to provide effective sedation and/or analgesia, implementation of a 
systematic efficient premedication in Neonatal Intensive Care Units is extremely 
heterogeneous as illustrated by declarative surveys reporting frequencies of systematic 
premedication ranging from 34%(8) to 93%(9) in different countries(8-12). Unfortunately, 
declarative surveys do not always provide reliable information and it is possible that an 
overestimation of premedication use is declared in this type of study. One observational study 
in France showed that 63% of neonates hospitalised in intensive care units did not receive any 
premedication prior to intubation(13). In the United Kingdom a recent observational study 
conducted in three tertiary neonatal units showed that premedication was used for 94% of 
intubations(14). In this latter study, morphine was the most commonly used drug in spite of 
its known prolonged action delay(15) and the lack of evidence supporting its superiority to 
placebo(16). These results suggest a large potential for practice improvement and underline 
the importance of epidemiological studies describing actual practices and possible gaps 
between these and knowledge. 
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In 2005 and 2006, a large regional longitudinal study (EPIPPAIN) was conducted in 13 
tertiary care centres to collect epidemiological data on neonatal pain(17). The present study 
was part of the EPIPPAIN study and was carried out in order to (i) describe the frequency and 
type of premedication used prior to endotracheal intubation, (ii) compare observed 
premedication practice to current recommendations, and (iii) identify factors associated with 
the absence of premedication use. 
Our hypothesis were that premedication rate would be low and rarely in accordance with 
published evidence. We also hypothesized that factors associated with the absence of 
premedication would be similar to those observed for the absence of analgesia for other 
painful procedures in the EPIPPAIN study(17).  
 
PATIENTS AND METHODS 
 
Study design 
Detailed methods were previously reported(17). The EPIPPAIN study (Epidemiology of 
Procedural Pain in Neonates) was designed as a prospective observational study to collect 
around-the-clock bedside data on all painful or stressful procedures performed in neonates 
admitted to the participating units. All 14 tertiary care centres, neonatal intensive care units 
(NICUs) and pediatric intensive care units (PICUs), in the Paris Region were invited to 
participate and 13 accepted the invitation. During the first 14 days of admission to the 
participating units, prospective data were collected on all neonatal procedures causing pain, 
stress, or discomfort with the corresponding analgesic therapy. Inclusion criterion was 
neonatal admission to the unit during the recruitment period, including preterm neonates 
younger than 45 postconceptional weeks and term neonates younger than 28 days. There were 
no exclusion criteria for these neonates. Demographic data, type, and duration of respiratory 
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support, sedative and analgesic drugs administered concomitantly or right before the 
procedure, and conditions related to each procedure (type, hour of the day) were collected. 
We also recorded repeated procedure attempts for procedures requiring more than 1 attempt 
before successful completion. Intubations were extracted from the initial database for specific 
analysis. In order to ensure independency between observations, only the first episode of 
intubation was considered for analysis if multiple intubations were performed in the same 
infant at different time points.  
 
Specific premedication definition 
Specific premedication was defined by the use of central nervous system depressants through 
IV or intranasal routes. Non-pharmacological analgesia such as sucrose or comforting 
measures was not considered as specific analgesia for intubation. Oral or intra-rectal routes 
were not considered as specific analgesia either because the onset delay related to these routes 
was considered too long. If an infant was receiving continuous intravenous sedation or 
analgesia at the time of intubation without additional treatment immediately prior to 
intubation, that was not considered as specific premedication. Two groups were defined: the 
group of intubations performed with a specific premedication (Premed group) and the group 
of intubations performed without any specific premedication (No premed group). 
 
Studied variables 
The EPIPPAIN study showed that the following factors were independently associated with 
the use of analgesia during a painful procedure(17): gestational age, type of respiratory 
support, parental presence, type of procedure, surgery, day of admission at the time of 
procedure, time of the day (day: 7:00 am to 6:59 pm, night: 7:00 pm to 6:59 am), continuous 
analgesia and clinical risk index for babies (CRIB) score(18). Another study has shown lower 
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rates of premedication in preterm compared to term neonates(13). Among factors studied in 
the EPIPPAIN study, we discarded parental presence since no intubation was performed in 
the presence of parents. We also discarded surgery during hospital stay because it could occur 
after the intubation procedure in an either expected or unexpected situation and could 
therefore not be considered as a factor influencing the clinician’s decision.  
We studied other parameters to further explore possible influence of global pain management 
at a patient- or centre-level on premedication use:  
- For all patients, we calculated the frequency of specific analgesia for all other painful 
procedures except intubation as a proxy for global analgesia management.  
- ICU type (NICU or PICU).  
- Centres were divided into two groups, above or below median, according to the 
frequency of analgesia for all procedures. This variable was created as a proxy for 
global pain management within a single unit.  
- Existing written protocol on premedication for neonatal endotracheal intubation at the 
time of the study. 
We collected from the database the availability of an intravenous access in patients from the 
No Premed group. We also collected the time sequence of procedures when patients had no 
IV access at the time of intubation. These data were used to explore potential practical 
barriers to drug injection. 
The number of intubation attempts was compared between groups. Distribution of the 
frequency of specific premedication was compared between centres. 
 
Guidance used as reference 
In the Premed group the guidance from the American Academy of  Pediatrics was the 
reference to classify premedication regimen as “preferred”, “acceptable”, “not recommended” 
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or “not described”(7). Although this guidance applies only to  nonemergent intubation and our 
study included all intubations, we considered that the majority, if not all, intubations carried 
out with a specific premedication in our study (Premed group) were nonemergent intubations. 
Emergent intubations are usually performed without premedication. Although this guidance 
was publised after the study was performed, it included all drugs recommended in the 
guidelines published in 2001(19) except for ketamine. It also included other drugs that were 
not mentionned in the previous recommendations and was the first to classify premedication 
regimens. 
 
Statistical analysis 
Chi-squared or Fisher’s exact tests were used to compare categorical variables and 
distribution of premedication among centres. For continuous variables, data were analysed 
with t-tests for normally distributed variables, and Mann-Whitney U tests for non-normally 
distributed variables. The infant and center characteristics of the Premed group and No 
premed group were compared for infants and centres characteristics in univariate analysis. A 
p value < 0.05 was considered significant. Multivariate analysis to identify factors associated 
with the absence of premedication was performed by creating a binary logistic regression 
model including all variables identified with a p value < 0.20 from univariate analysis. 
Analyses were performed with SPSS, version 19.0 (SPSS Inc. Chicago, IL, USA). 
 
Ethics 
The local committee for the protection of human subjects reviewed the study protocol. 
Because this was an observational study with no changes in the standard of care, the human 
subjects committee established that further approvals or parental consent were not required 
according to French law. The computerized data collection was approved by the French Data 
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Protection Authority (Commission Nationale de l’Informatique et des Libertés). 
 
 
RESULTS 
During the study period 430 infants were admitted to participating units. A total of 101 
tracheal intubations were performed in 91 patients (10 infants were intubated twice). Ninety-
one intubations were analysed  (only the first intubation was considered for analysis in infants 
with two intubations). In 51 cases (56 %) a specific premedication was administered before 
intubation. No intubation initially attempted without premedication was ultimately performed 
with a premedication. We found 13 different types of premedication regimens (Table 1). 
Opioids were the most commonly used drugs and were used in 34 (67%) of 51 
premedications. Opioids used included sufentanil (n=13), nalbuphine (n=8), fentanyl (n=8) 
and morphine (n=6 including 1 in combination with fentanyl). Midazolam was the only 
benzodiazepine used and it was the second most frequent premedication. It was used in 27 
(53%) of 51 premedications including 26 by the IV route and 1 by the intranasal route. 
Propofol was used alone in 4 occurrences (8% of premedications)  and a neuromuscular 
blocker was used once in association with sufentanil. Overall, an association of drugs was 
used in 17 cases (33%).  
Adequacy of administered premedication with current recommendations is summarized in 
Table 1. The majority of premedications consisted in “not described” protocols (43%). 
“Preferred” and “acceptable” premedications as defined by the AAP accounted for 30% of 
premedications. 
 Characteristics of the Premed and No premed groups are shown in Table 2. The median age 
at intubation was significantly lower in the No premed group than in the Premed group (0.7 vs 
2.0 days, p=0.04). Spontaneous breathing was more frequent in the No premed group than in 
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the Premed group (32% vs 12%, p=0.02). The median percentage of analgesia for all other 
painful procedures was significantly higher in the No premed group than in the Premed group 
(16% vs 6%, p=0.03). All other studied variables did not differ between groups. Forteen out 
of 40 (35%) intubations and 13 out of 51 (25%) intubations were performed in the No premed 
and the Premed groups respectively, while the neonate was receiving a continuous sedation-
analgesia at the time of intubation (p=0.36). Continuous infusions of sedative and/or 
analgesics included morphine, fentanyl, sufentanil, nalbuphine and midazolam in both the no 
premedication group and the premedication group. Thus, of all 91 intubations, 26 (29%) were 
carried out with neither continuous sedation and/or analgesia nor specific premedication right 
before intubation. In the No Premed group 34 (85%) infants had an available intravenous 
access at the time of intubation. Of  the 6 infants who had no IV access at the time of 
intubation, 4 had an umbilical venous catheter or a peripheral line placement within the 60 
minutes following the intubation procedure.  
Rates of premedication use were significantly different among centres (p=0.04) (Figure 1). 
Multivariate analysis including age at intubation (aOR=1.01, [95%CI, 0.98 ; 1.05]), daytime 
vs nighttime (aOR=1.65, [95%CI, 0.65 ; 4.17]), spontaneous breathing vs ventilatory support 
(aOR=0.46, [95%CI, 0.14 ; 1.53]) and percentage of analgesia for all other painful procedures 
(aOR=0.99, [95%CI, 0.97 ; 1.00]) did not identify any independent factor associated with the 
absence of premedication use. 
 
DISCUSSION 
This prospective, around-the-clock, observational study on “real life” practice found that, in 
intensive care centres of the biggest French region,  44% of intubations were performed 
without any specific prior analgesia or sedation confirming our hypothesis of low 
premedication rate. Twenty-nine per cent of intubations were carried out with neither 
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continuous sedation and/or analgesia nor specific premedication prior to intubation. These 
painful and stressful awake intubations were performed although it has been shown for 
decades that they may cause hypoxemia(20), bradycardia(21) and intracranial 
hypertension(22). The participation of 13 of  all 14 centres in this region ensure that the 
results are representative of neonatal intensive care in the Paris region and they probably also 
reflect national practices(17). 
The 56% rate of premedication for endotracheal intubations found in this study is higher than 
the 37% rate reported in French intensive care units in 2001(13) but it is still lower than the 
74% rate from a declarative survey performed in 2003(12).  
 
We found 13 different regimens used in 51 premedications. Similarly, an Australian survey 
found 7 different drug combinations used routinely and another one carried out in the UK 
reported 14 different drug combinations(11). Opioids were the most frequently used drugs for 
premedication. Although fentanyl has been the most extensively studied opioid for intubations 
in neonates(23-25), sufentanil and nalbuphine were the most frequently used opioids. Very 
few studies have been reported with sufentanil or nalbuphine in neonates. Sufentanil has been 
shown to have satisfactory hemodynamic(26) and respiratory(27) tolerance in preterm 
neonates. Nevertheless, to date, no publication has reported the efficacy or tolerance  of 
sufentanil for neonatal tracheal intubation. Nalbuphine is an agonist-antagonist opioid that 
induces less respiratory depression than morphine in adults due to its ceiling effect(28) but it 
has never been prospectively assessed in the neonate. Although morphine is very popular in 
some countries such as the United Kingdom(9, 14), it was rarely used in our study. There is 
no evidence in the literature supporting its use for tracheal intubation(16, 29).  Midazolam 
was the most frequently single drug used prior to tracheal intubation in our study. This 
leading position among all drugs in France in this setting was already observed by Simon et 
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al. in 2001(13). The wide popularity of midazolam for intubations in neonates contrasts with 
the lack of evidence sustaining its use. A randomised controlled trial studying midazolam and 
atropine as a premedication prior to intubation was prematurely interrupted because of 
frequent severe adverse events(30). In combination with remifentanil no such adverse events 
were observed in a limited number of patients(31, 32). Midazolam has been popular in France 
possibly because of its mild sedative effects, which allow the persistence of spontaneous 
breathing that can be reassuring for the operator. Propofol was used in 4 out of 51 (8%)  
premedicated intubations in our study.  This drug might become popular among 
neonatologists because of its ease of use (single drug, short effect)(31, 33). However, 
concerns have been raised about its hypotensive effect in preterm infants(34, 35). Nalbuphine 
and propofol are currently used off-label because data are insufficient to permit drug approval 
for prescription in neonates. Furthermore, the generic status of opioids, midazolam and 
propofol considerably reduces the financial interest that pharmaceutical companies would 
have to promote trials in order to obtain term-specific data or neonatal marketing 
authorization.  
Overall, the practices observed in our study were rarely in adequacy with published evidence 
or current recommendations. We categorized practices according to recommendations issued 
after our observational study was carried out. This choice could be argued. We, nevertheless, 
decided to use this guidance as a reference because it was the only one classifying drugs as 
“recommended”, “acceptable” or “not recommended”. Concerning differences between 
guidelines, the recent guidance that we used did not include ketamine as previous 
recommendations from the AAP published in 2001(19) did. Ketamine use was, in fact, never 
observed in our study.  Also, the guidance from 2010 is less restrictive than the previous one 
since it recommends more drugs. In addition, publications existing at the time of our study 
had already shown the advantages and disadvantages of different drug combinations. For 
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example, it had been strongly suggested that midazolam should not be used as a single drug 
for premedication(30). In our study, midazolam was used in 25% of premedicated intubations. 
It had also been advocated in 2001 that the combination of a synthetic opioid and a muscle 
relaxant had one of the best benefits/risks ratios(36). This combination was observed only 
once in our study. The majority (43%) of drug or drug combinations that were observed have 
not been reported in the literature for intubation in the neonate.  At the time of the study no 
national guidelines existed. In order to avoid misuse or underuse of drugs, it seems necessary 
that national authorities and scientific societies issue guidelines on this topic; this would 
contribute to the implementation of evidence-based practice. The lack of recommendations 
can probably explain the observed heterogeneity in practice. The observed results suggest, as 
well, a possible insufficient medical knowledge of practitioners on this topic. 
 
In univariate analysis, we found that the absence of specific premedication was more frequent 
in infants who were younger. Premedication was also less frequent in infants who were not 
receiving  respiratory support as compared to those who were receiving non invasive 
ventilation or invasive ventilation (reintubations) at the time of intubation. It was less frequent 
in those infants who received a higher rate of analgesia for all other painful procedures. We 
do not have a clear explanation for this practice. The existence of a local written protocol was 
not associated with a more frequent use of premedication in our study. In the multivariable 
analysis we confirmed the direction of the associations reported above including increasing 
age at intubation, daytime vs nighttime, spontaneous breathing vs ventilatory support and 
percentage of analgesia for all other painful procedures. However no factor remained 
significant in this multivariable analysis, suggesting a lack of power to identify predictive 
factors. Multivariate analysis did not identify patient- or centre-related factors associated with 
the absence of premedication rejecting our hypothesis that factors already identified in the 
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EPIPPAIN study would be confirmed. The fact that factors that were associated with 
analgesia use in the Epippain study were not associated with premedication use in the present 
study suggests that intubations were not managed as other painful procedures. We should 
state, however, that our model probably lacked other relevant variables because operator-
related variables (experience, apprehension) and circumstances of intubation (urgent, semi-
urgent or planned) were not collected. It is plausible that other relevant factors were not 
included in our model. This model could also have been underpowered to show more subtle 
associations. These limitations should be kept in mind when interpretating the results. A 
potential barrier to premedication administration could have been unavailable IV access. Our 
results do not support this hypothesis since 85% of infants in the No Premed group already 
had an IV access at the time of intubation. Only 6 infants were intubated without an IV 
access. We do not know the exact reasons for this but we speculate that an IV line was not 
placed prior to intubation because  either an immediate intubation was needed as part of 
resucitation following an acute deterioration or the clinician estimated that obtaining an IV 
access to provide a specificpremedication before intubation in order to manage pain and stress 
was not a priority.   Interistingly, in adult patients awake intubation is only considered if the 
patient is completely unresponsive, nearly dead or in cardiac arrest(6). Awake intubations are 
still common in neonates, though in 2001, a consensus statement from the International 
Evidence-Based Group for Neonatal Pain concluded that “tracheal intubation without the use 
of analgesia or sedation should be performed only for resuscitation in the delivery room or for 
life-threatening situations associated with the unavailability of intravenous access”(19). It is 
possible that concerns about prolonged intubation procedures or unsuccessful intubations lead 
clinicians to avoid premedication in some occasions. These concerns contrast with published 
data showing that premedication decreases procedure time(25, 29, 33) and increases success 
rates(2, 32, 37). We did not find a difference in gestational age of premedicated and no 
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premedicated infants. This differs from the findings of Simon et al. who reported a lower rate 
of premedication in preterm infants(13). Though in univariate analysis premedicated infants 
were older (median age of 2 days) than non premedicated ones (median age of 0.7 days), in 
multivariable analysis this difference was not significant.  
 
Since the EPIPPAIN study was not initially designed to study risk factors for the absence of 
premedication prior to neonatal endotracheal intubation, we consider that our study has two 
main limitations. First we were not able to collect specific information on either the indication 
of intubation or the experience of the operator which could be considered as potential risks 
factors for the absence of premedication. We did not collect information on the tolerance of 
intubation either. Thus, we ignore which were elective, semi-urgent or urgent intubations. In 
fact, there is currently neither a clear definition of emergent intubation nor clear evidence of 
usual rates of emergent intubation in neonates admitted to NICUs. For exemple, two 
randomised controlled trials comparing two types of premedication for nonemergent neonatal 
intubation reported rates of emergent intubation without providing precise criteria for this 
categorisation. Roberts et al.(25) reported a 21% rate of emergent intubation in the NICU. In 
another study, Choong et al.(38) found a 86% rate of emergent intubation. Objective criteria 
for defining emergent intubations are required so that results of future studies can be 
compared. We speculate that in our study emergent intubations did not explain the observed 
lack of premedication because in our empirical experience emergent intubations do not 
account for 45% of all intubations in the NICU or PICU; we do not have, however, published 
data to support this speculation.  
Second, our study had insufficient power to show subtle differences between intubations 
performed with and without premedication. For instance, unlike a previously reported 
study(2),  we did not observe a difference in the number of attempts according to the use of 
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premedication. Moreover, since the overall success rate for the first intubation attempt was 
higher (69%) than in other studies, the left margin for success rate improvement was limited  
 
Our results highlight the difficulties of implementing evidence-based practices in daily care. 
Effective interventions to change practice are not clearly recognized yet  but require 
identification of barriers as a first step(39). Possible barriers to good practice include 
historical local practices as illustrated by the persistence of midazolam use in France and the 
variability observed among units. It has been reported that in many areas of medicine there is 
a large chasm between what we know and what we do(40, 41). This seems to be true of 
efforts to improve neonatal pain management as well and supports the need to develop tools 
to translate research into practice. In one study, collaborative use of quality improvement 
methods resulted in the creation of logical, efficient, and effective processes to improve 
neonatal pain management(40). At our regional level, we have used our results to try to 
increase the rate of premedication for neonatal intubations. We have presented our results to 
staff representing participating centres and discussed about possible strategies. Further 
communication and education on this subject is planned in future national medical 
congresses. 
Efforts should be made to reach a consensus and to establish and spread sound guidelines 
concerning premedication prior to neonatal tracheal intubation. The involvement of national 
and international scientific societies seems crucial for this process. Tailored collaborative 
interventions should also be carried out in order to implement evidence-based practice at 
bedside and to decrease painful experiences in hospitalised neonates. 
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